Enfusion Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	774	1,237	1,103	2,367	-	-
Market Cap Growth	-2.12%	12.12%	-53.41%	-	-	-
Enterprise Value	756	1,216	1,047	2,303	85	22
PE Ratio	280.67	205.24	-144.10	-14.95	-	-
PS Ratio	4.26	7.09	7.34	21.19	-	-
PB Ratio	13.33	23.04	16.97	42.81	-	-
P/FCF Ratio	47.26	77.46	177.17	-284.13	-	-
P/OCF Ratio	29.49	48.24	77.91	-7444.52	-	-
EV/Sales Ratio	4.17	6.97	6.97	20.62	1.06	0.37
EV/EBITDA Ratio	34.23	51.80	222.75	-15.44	10.02	1.45
EV/EBIT Ratio	288.95	183.88	-149.77	-15.04	13.75	1.57
EV/FCF Ratio	46.20	76.20	168.25	-276.40	-24.87	2.76
Debt / Equity Ratio	0.27	0.29	0.11	-	-0.42	-0.23
Debt / EBITDA Ratio	0.70	0.66	1.49	-	11.67	1.84
Debt / FCF Ratio	0.94	0.97	1.12	-	-28.96	3.51
Quick Ratio	3.67	3.14	5.09	10.19	2.45	1.84
Current Ratio	4.08	3.44	5.57	11.06	2.72	2.00
Asset Turnover	1.75	1.64	1.32	1.54	2.55	-
Interest Coverage	-	-	-	-33.34	3.70	19.15
Return on Equity (ROE)	4.80%	11.10%	-12.70%	177.60%	-2.30%	-
Return on Assets (ROA)	2.40%	5.70%	-6.70%	-218.10%	13.00%	-
Return on Capital (ROIC)	5.00%	12.62%	-16.62%	-498.92%	-4.07%	-14.80%
Earnings Yield	0.33%	0.49%	-0.69%	-6.69%	-	-
FCF Yield	2.12%	1.29%	0.56%	-0.35%	-	-
Buyback Yield / Dilution	32.37%	-51.57%	-2.83%	26.54%	-	-
Total Shareholder Return	32.37%	-51.57%	-2.83%	26.54%	-	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).